AMRN Stock Analysis: Buy, Sell, or Hold?
AMRN - Amarin Corp Plc
$16.37
-0.10 (-0.61%)
▼
5d:
+0.12%
30d:
+13.13%
90d:
+11.82%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Jul 29, 2026
22d
Get Alerted When AMRN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AMRN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: AMRN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$23.76
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$14.75
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AMRN is currently trading at $16.37, which is considered extended relative to its 30-day fair value range of $14.43 to $16.08. The stock's valuation (Forward PE: 16.7) is in line with its historical norms (17.3). Remarkably, the market is currently pricing in an annual earnings decline of 1.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, AMRN is showing sideways momentum. Immediate support is located at $15.16, while resistance sits at $17.25.
Market Sentiment: AMRN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $12.50. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AMRN is showing sideways momentum. Immediate support is located at $15.16, while resistance sits at $17.25.
Market Sentiment: AMRN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $12.50. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$14.43 -
$16.08
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 23.6% above Wall St target ($12.50)
Trading Range Analysis
30-Day Trading Range
$14.43 -
$16.08
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$15.16
Resistance Level
$17.25
Current Trend
Sideways
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.70
Wall Street Target
$12.50
(-23.6%)
Revenue Growth (YoY)
7.4%
Earnings Growth (YoY)
-94.2%
Profit Margin
-15.5%
Valuation Discount vs History
-1.2% cheaper
PE vs Historical
16.7 vs 17.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.2%
(market-implied from PE analysis)
1-Year Target
$16.17
(-1%)
2-Year Target
$15.98
(-2%)
3-Year Target
$15.79
(-4%)
3-Yr Target (if PE normalizes)
(PE: 17→17)
$16.35
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.7 to 17.3
Stabilization Target:
$16.95
(+3.6%)
PE Expansion Potential:
+3.6%
Share & Embed Analysis
Last updated: July 06, 2026 5:40 AM ET
Data refreshes hourly during market hours. Next update: 6:40 AM
Data refreshes hourly during market hours. Next update: 6:40 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AMRN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1220 | 61 BUY |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$158 | 67 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$355 | 69 BUY |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$220 | 67 BUY |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$256 | 60 HOLD |
